BRCA1 and breast cancer: Other studies have, instead, been performed in order to characterize a set of immunohistochemical and pathological markers that could help to distinguish the non-BRCA1/2 familial tumors from the familial cancers carrying these gene mutations, demonstrating the heterogeneity of familial BC [2, 17].